Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by cartach13on Dec 15, 2008 8:54pm
367 Views
Post# 15647620

RE: RE: RE: why doesn't ONC SP respond like this?

RE: RE: RE: why doesn't ONC SP respond like this? I first became aware of ONC some years back when it first came on the scene. Did'nt buy any shares at the time and watched it run up to,as I recall, around $13 a share. Later I bought in  just over $2 and have been holding since. Although I don't have any other biotech stocks but ONC and am not that familiar with the sector I know that biotechs in general have been underperforming and out of favor for a considerable period of time. In that regard are there that many biotech stocks recently that have been "runaways"  or are they very few and far between? And could'nt ONC's share price moves,even though the prospects look good, just be reflecting that rather than any other reasons.  Just a thought.
Bullboard Posts